Predict your next investment

Venture Capital
northcoastvc.com

See what CB Insights has to offer

Investments

39

Portfolio Exits

6

Funds

4

About North Coast Technology Investors

North Coast Technology Investors is a venture capital firm with approximately $100 million under management that actively invests in technology-driven companies at their earliest stages. North Coast's goal is to back entrepreneurs who seek to build transformative enterprises in the Midwest.

North Coast Technology Investors Headquarter Location

206 South 5th Avenue Suite 550

Ann Arbor, Michigan, 48104-2268,

United States

734-662-7667

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest North Coast Technology Investors News

BlueWillow Biologics Closes $10M Series A Financing

May 7, 2018

NanoBio Corporation, an Ann Arbor, Mich.-based clinical-stage biopharmaceutical company, changed its corporate name to BlueWillow Biologics and closed a $10m Series A financing. The round was led by North Coast Technology Investors, Line Moon Ventures and the University of Michigan through its MINTS initiative. The company intends to use the funds to continue to advance its novel intranasal technology to develop new vaccines for several respiratory and sexually transmitted diseases. Led by Dave Peralta, Chief Executive Officer, BlueWillow Biologics is a biopharmaceutical company focused on developing and commercializing intranasal vaccines using its patented NanoVax® technology platform. The technology employs a novel oil-in-water nanoemulsion adjuvant that is effective when administered via intranasal or intramuscular vaccination, and can elicit both mucosal and systemic immunity when applied intranasally. The company is currently developing intranasal vaccines for several respiratory and sexually transmitted infections, including RSV, pertussis, influenza, anthrax, prophylactic and therapeutic HSV-2 and chlamydia. FinSMEs

North Coast Technology Investors Investments

39 Investments

North Coast Technology Investors has made 39 investments. Their latest investment was in BlueWillow Biologics as part of their Series B - II on April 4, 2020.

CBI Logo

North Coast Technology Investors Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/8/2020

Series B - II

BlueWillow Biologics

$8.19M

No

1

11/12/2019

Series B

VNN

$3.55M

No

1

6/28/2019

Series A

Larky

$2.12M

No

1

3/26/2019

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

10

5/7/2018

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/8/2020

11/12/2019

6/28/2019

3/26/2019

5/7/2018

Round

Series B - II

Series B

Series A

Unattributed VC

Series A - II

Company

BlueWillow Biologics

VNN

Larky

Subscribe to see more

Subscribe to see more

Amount

$8.19M

$3.55M

$2.12M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

North Coast Technology Investors Portfolio Exits

6 Portfolio Exits

North Coast Technology Investors has 6 portfolio exits. Their latest portfolio exit was VNN on March 02, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/2/2022

Merger

$99M

1

10/28/2013

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/26/2013

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

1/20/2010

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

7/7/2005

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/2/2022

10/28/2013

9/26/2013

1/20/2010

7/7/2005

Exit

Merger

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

0

10

North Coast Technology Investors Fund History

4 Fund Histories

North Coast Technology Investors has 4 funds, including NCTI IV.

Closing Date

Fund

Fund Type

Status

Amount

Sources

11/15/2017

NCTI IV

Early-Stage Venture Capital

Open

$4M

1

12/21/2009

NCTI II

$99M

10

7/1/2009

NCTI III

Subscribe to see more

Subscribe to see more

$99M

10

12/31/1999

North Coast Technology Investors LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

11/15/2017

12/21/2009

7/1/2009

12/31/1999

Fund

NCTI IV

NCTI II

NCTI III

North Coast Technology Investors LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Open

Subscribe to see more

Subscribe to see more

Amount

$4M

$99M

$99M

$99M

Sources

1

10

10

10

North Coast Technology Investors Team

1 Team Member

North Coast Technology Investors has 1 team member, including current Founder, Lindsay Aspegren.

Name

Work History

Title

Status

Lindsay Aspegren

Founder

Current

Name

Lindsay Aspegren

Work History

Title

Founder

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.